• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

苯并吗啡烷骨架,适用于不同靶点的多功能支架:全面综述。

Benzomorphan skeleton, a versatile scaffold for different targets: A comprehensive review.

机构信息

Department of Drug Sciences, Medicinal Chemistry Section, University of Catania, Viale A. Doria, 6, 95100, Catania, Italy.

Department of Drug Sciences, Pharmaceutical Technology Section, University of Catania, Viale A. Doria 6, 95125, Catania, Italy.

出版信息

Eur J Med Chem. 2018 Jul 15;155:492-502. doi: 10.1016/j.ejmech.2018.06.017. Epub 2018 Jun 7.

DOI:10.1016/j.ejmech.2018.06.017
PMID:29908442
Abstract

Despite the fact that the benzomorphan skeleton has mainly been employed in medicinal chemistry for the development of opioid analgesics, it is a versatile structure. Its stereochemistry, as well as opportune modifications at the phenolic hydroxyl group and at the basic nitrogen, play a pivotal role addressing the benzomorphan-based compounds to a specific target. In this review, we describe the structure activity-relationships (SARs) of benzomorphan-based compounds acting at sigma 1 receptor (σ1R), sigma 2 receptor (σ2R), voltage-dependent sodium channel, N-Methyl-d-Aspartate (NMDA) receptor-channel complex and other targets. Collectively, the SARs data have highlighted that the benzomorphan nucleus could be regarded as a useful template for the synthesis of drug candidates for different targets.

摘要

尽管苯并吗啡烷骨架主要用于开发阿片类镇痛药的药物化学,但它是一种多功能结构。其立体化学以及酚羟基和碱性氮的适时修饰,对于将苯并吗啡烷类化合物靶向特定靶标起着至关重要的作用。在这篇综述中,我们描述了苯并吗啡烷类化合物在 sigma 1 受体(σ1R)、sigma 2 受体(σ2R)、电压门控钠离子通道、N-甲基-D-天冬氨酸(NMDA)受体-通道复合物和其他靶点上的构效关系(SAR)。总的来说,SAR 数据表明,苯并吗啡烷核可以被视为合成针对不同靶点的候选药物的有用模板。

相似文献

1
Benzomorphan skeleton, a versatile scaffold for different targets: A comprehensive review.苯并吗啡烷骨架,适用于不同靶点的多功能支架:全面综述。
Eur J Med Chem. 2018 Jul 15;155:492-502. doi: 10.1016/j.ejmech.2018.06.017. Epub 2018 Jun 7.
2
Benzomorphan scaffold for opioid analgesics and pharmacological tools development: A comprehensive review.苯并吗啡烷骨架在阿片类镇痛药和药理学工具开发中的应用:全面综述。
Eur J Med Chem. 2018 Mar 25;148:410-422. doi: 10.1016/j.ejmech.2018.02.046. Epub 2018 Feb 17.
3
Exploiting the Power of Stereochemistry in Drug Action: 3-[(2,6,11)-8-Hydroxy-6,11-dimethyl-1,4,5,6-tetrahydro-2,6-methano-3-benzazocin-3(2)-yl]--phenylpropanamide as Potent Sigma-1 Receptor Antagonist.利用立体化学在药物作用中的力量:3-[(2,6,11)-8-羟基-6,11-二甲基-1,4,5,6-四氢-2,6-甲撑-3-苯并氮杂卓-3(2)-基]--苯基丙酰胺作为有效的西格玛-1 受体拮抗剂。
ACS Chem Neurosci. 2020 Apr 1;11(7):999-1005. doi: 10.1021/acschemneuro.9b00688. Epub 2020 Mar 23.
4
Synthesis and structure-activity relationships of 6,7-benzomorphan derivatives as antagonists of the NMDA receptor-channel complex.6,7-苯并吗啡烷衍生物作为N-甲基-D-天冬氨酸受体通道复合物拮抗剂的合成及构效关系
J Med Chem. 1997 Aug 29;40(18):2922-30. doi: 10.1021/jm970131j.
5
N-methyl-D-aspartate receptor channel block by the enantiomeric 6,7-benzomorphans BIII 277 CL and BIII 281 CL.对映体6,7-苯并吗啡烷BIII 277 CL和BIII 281 CL对N-甲基-D-天冬氨酸受体通道的阻断作用
J Pharmacol Exp Ther. 1998 May;285(2):767-76.
6
(2S)-N-2-methoxy-2-phenylethyl-6,7-benzomorphan compound (2S-LP2): Discovery of a biased mu/delta opioid receptor agonist.(2S)-N-2-甲氧基-2-苯乙基-6,7-苯并吗啡烷化合物(2S-LP2):一种偏向性 μ/δ 阿片受体激动剂的发现。
Eur J Med Chem. 2019 Apr 15;168:189-198. doi: 10.1016/j.ejmech.2019.02.043. Epub 2019 Feb 18.
7
Synthesis and pharmacology of 8-amino-3-[(tetrahydro-2-furanyl)methyl] benzomorphan.8-氨基-3-[(四氢-2-呋喃基)甲基]苯并吗啡烷的合成与药理学
Yao Xue Xue Bao. 2003 Oct;38(10):748-53.
8
Novel Sigma-1 receptor antagonists: from opioids to small molecules: what is new?新型 Sigma-1 受体拮抗剂:从阿片类药物到小分子:有何新进展?
Future Med Chem. 2018 Jan;10(2):231-256. doi: 10.4155/fmc-2017-0164. Epub 2017 Nov 29.
9
Asymmetric synthesis of 9-alkyl-2-benzyl-6,7-benzomorphans: characterization as novel sigma receptor ligands.9-烷基-2-苄基-6,7-苯并吗啡烷的不对称合成:作为新型σ受体配体的表征
J Med Chem. 1999 Nov 4;42(22):4621-9. doi: 10.1021/jm990169r.
10
Evaluation of N-substitution in 6,7-benzomorphan compounds.6,7-苯并吗啡烷类化合物 N-取代基的评价。
Bioorg Med Chem. 2010 Jul 15;18(14):4975-82. doi: 10.1016/j.bmc.2010.06.005. Epub 2010 Jun 9.

引用本文的文献

1
Novel sigma 1-antagonists with -(+)-normetazocine scaffold: synthesis, molecular modeling, and antinociceptive effect.具有-(+)-去甲美他唑辛骨架的新型σ1拮抗剂:合成、分子模拟及镇痛作用
RSC Med Chem. 2024 Nov 29;16(3):1172-1187. doi: 10.1039/d4md00397g. eCollection 2025 Mar 19.
2
Dual Piperidine-Based Histamine H and Sigma-1 Receptor Ligands in the Treatment of Nociceptive and Neuropathic Pain.基于哌啶的组胺 H 和西格玛-1 受体双重配体在治疗伤害感受性和神经性疼痛中的应用。
J Med Chem. 2023 Jul 27;66(14):9658-9683. doi: 10.1021/acs.jmedchem.3c00430. Epub 2023 Jul 7.
3
Novel -normetazocine Derivatives with Opioid Agonist/Sigma-1 Receptor Antagonist Profile as Potential Analgesics in Inflammatory Pain.
新型具有阿片激动剂/σ-1 受体拮抗剂特性的诺美他嗪衍生物,有望成为治疗炎症性疼痛的镇痛药。
Molecules. 2022 Aug 12;27(16):5135. doi: 10.3390/molecules27165135.
4
Structural and Molecular Insight into Piperazine and Piperidine Derivatives as Histamine H and Sigma-1 Receptor Antagonists with Promising Antinociceptive Properties.哌嗪和哌啶衍生物作为组胺 H 和 sigma-1 受体拮抗剂的结构和分子见解,具有有前景的抗伤害感受特性。
ACS Chem Neurosci. 2022 Jan 5;13(1):1-15. doi: 10.1021/acschemneuro.1c00435. Epub 2021 Dec 15.
5
LP1 and LP2: Dual-Target MOPr/DOPr Ligands as Drug Candidates for Persistent Pain Relief.LP1 和 LP2:作为治疗持续性疼痛候选药物的双重靶向 MOPr/DOPr 配体。
Molecules. 2021 Jul 8;26(14):4168. doi: 10.3390/molecules26144168.
6
Novel -Substituted Benzomorphan-Based Compounds: From MOR-Agonist/DOR-Antagonist to Biased/Unbiased MOR Agonists.新型取代苯并吗啡烷类化合物:从MOR激动剂/DOR拮抗剂到偏向/非偏向MOR激动剂
ACS Med Chem Lett. 2020 Jan 28;11(5):678-685. doi: 10.1021/acsmedchemlett.9b00549. eCollection 2020 May 14.